The 2nd Microbiome Movement - Maternal and Infant Health Summit returns as the only conference to unite large pharma, drug developers, academic KOL's and pediatric clinicians to discuss the shared challenges of helping to configure the microbiome in the first 1000 days of life to reduce risk of chronic health conditions.
With a global rise of incidences of allergies, atopic march and childhood metabolic disorders, the infant microbiome in this first 1000 days represents a key window of opportunity to create products and solutions to target and prevent the onset of these chronic health conditions.
Join leaders in the maternal-infant microbiome space as they present the latest data-driven research, an update on partnerships and insights into how future research could be conducted to benefit the field as we unlock the secrets of the infant microbiome to proactively prevent disease.
Early booking and group discounts apply, start-up and academic rates are available - see the website for details.
Time: 09:00 to 17:00
Industry Conference Early Bird (until August 14): USD 1399.00,
Academic Conference Early Bird (until August 14): USD 999.00,
Student and Post-Doc Early Bird (until August 14): USD 599.00
Speakers: Alessio Fasano, Professor and Director Mucosal Immunology and Biology Research Center, Massachusetts General Hospital, Aurélien Baudot, International Business Development, ProDigest, Ben Callahan, Assistant Professor, NC State University, Meghan Azad, University of Manitoba, Nikole Kimes, Siolta Therapeutics, Chris Damman, Bill and Melinda Gates Foundation, David Kyle, Evolve Biosystems, Dirk Gevers, Johnson and Johnson, David Sela, University of Massachusetts Amherst, Dorrotya Nagy-Szakai, Biotia, Inc., Stacy Kahn, Hepatology and Nutrition Boston Children's Hospital, Katherine Gregory, Brigham and Women's Hospital, Dr Georg Gerber, Brigham and Women's Hospital, Noel Muller, John Hopkins University, Maureen Leonard, Massachusetts General Hospital, Victoria Martin, Massachusetts General Hospital, Xue-Jun (June) Kong, Massachusetts General Hospital, Elena Medo, Medolac Laboratories, Michelle McGuire, University of Idaho, Sharon Donovan, University of Illinois, Padmaja Subbarao, University of Toronto and McMaster University, Rose Szabady, Vedanta Bioscience, Herwig Bachmann